Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
HOYNG ROKH MONEGIER is the ‘go-to firm for EU regulatory matters in pharma, medical devices, and biotech’, advising across the life cycle of medical products and devices. The practice’s expertise extends to regulatory exclusives, market authorisation and access, and compliance issues, with members of the team also being skilled at handling domestic and cross-border litigation. Team head Liesbeth Weynants ’stands out for her superb knowledge of pharma regulatory law combined with patent litigation expertise’. Tim Robrechts and Ine Letten are noted for their intellectual property expertise, with Letten also being highly knowledgeable of pharmaceutical regulatory law.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘They excel in their advice relating to pharmaceutical regulatory law and are very well connected locally to advise on national legislative changes and decisions.’
‘Liesbeth Weynants stands out for her superb knowledge of pharma regulatory law combined with patent litigation expertise.’
Clients clés
- BioNTech
- Teva